Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, covering all aspects of healthcare, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies, and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest

Jan 23, 2018, 16:30 ET Data from RG7916 Programs in SMA to be Presented at the International Scientific Congress on Spinal Muscular Atrophy

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that updates and preliminary data from ongoing clinical trials of RG7916, an oral survival...


Jan 23, 2018, 16:05 ET QIAGEN Receives FDA Clearance for First-Ever JAK2 Test for Use in Diagnosis of Additional Myeloproliferative Neoplasms

QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today that it has received clearance for its ipsogen JAK2 RGQ PCR Kit (ipsogen JAK2...


Jan 23, 2018, 16:00 ET Lyric Pharmaceuticals Presents Data at ASPEN Conference on the Incidence of Enteral Feeding Intolerance in the ICU

Lyric Pharmaceuticals, Inc (Lyric), a biopharmaceutical company, today announced the presentation at the ASPEN 2018 Nutrition Science and Practice...


Jan 23, 2018, 13:00 ET Comprehensive Research Assessing Study Startup Published in Therapeutic Innovation & Regulatory Science

goBalto, Inc., the leading provider of cloud-based clinical study startup solutions, announced today the publication of the peer-reviewed article...


Jan 23, 2018, 12:23 ET Frontiers in Physiology Publishes Research Showing Pro-Arrhythmia Risk Predictivity of Adult Human Primary Ventricular Tissue-Based Model

First-of-its-kind preclinical ex-vivo human cardiac research conducted by AnaBios and Amgen, published today in the journal Frontiers in...


Jan 23, 2018, 12:09 ET MCRA Assists IlluminOss Medical with Successful De Novo Decision: 1st Orthopedic De Novo Granted by the FDA

Musculoskeletal Clinical Regulatory Advisers, LLC (MCRA) has announced its role in the successful granting of the first orthopedic de novo by the...


Jan 23, 2018, 09:00 ET Scientists Synthesize Nanoparticle-Antioxidants to Treat Strokes and Spinal Cord Injuries

An international science team has developed an innovative therapeutic complex based on multi-layer polymer nano-structures of superoxide...


Jan 23, 2018, 09:00 ET Longeveron Shares Promising State of Regenerative Medicine Research with Experts at the FDA, NIH and Other Leading Organizations at National Conference

The early results of mesenchymal stem cells studies look encouraging for lessening or reversing the effects of Aging Frailty, Joshua M. Hare, M.D.,...


Jan 23, 2018, 08:45 ET Biomarck Announces the Start of a Phase 2 Clinical Trial of BIO-11006 for Non-Small Cell Lung Cancer (NSCLC)

Biomarck Pharmaceuticals, Ltd today announced that a Phase 2 clinical study in advanced NSCLC has commenced. This study at 10 sites in India...


Jan 23, 2018, 08:35 ET Study Finds Leaf System Offers Patients Significant Protection Against Pressure Injuries

A new clinical study by researchers at Stanford Health Care looked at whether a wearable patient sensor could improve patient outcomes. The study,...


Jan 23, 2018, 08:01 ET Superbactéries: première comparaison indépendante de la contribution des entreprises pharmaceutiques à la lutte contre les infections résistantes aux antibiotiques

La première analyse indépendante de la contribution de l'industrie pharmaceutique à la lutte contre la résistance aux médicaments, publiée ce...


Jan 23, 2018, 08:01 ET Superbugs: First Independent Comparison of Pharma Companies' Efforts to Address Drug-resistant Infections

The first independent analysis of pharmaceutical industry efforts to tackle drug resistance, published today, finds that as well as...


Jan 23, 2018, 08:01 ET Multiresistente Keime: Erster unabhängiger Vergleich zu den Bemühungen von Pharma-Unternehmen bei der Bekämpfung resistenter Infektionen

Die erste unabhängige Analyse der Pharma-Industrie zum Thema antimikrobielle Resistenzen (AMR) legt offen, dass die Unternehmen neben der...


Jan 23, 2018, 08:00 ET BioLineRx Presents Preclinical Data at ASCO-SITC Showing BL-8040 Prolongs Survival by Mediating Tumor Infiltration of Antigen-Specific T-cells

BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX) (TASE: BLRX.TA) a clinical-stage biopharmaceutical company focused on oncology and immunology,...


Jan 23, 2018, 07:30 ET ProMIS Neurosciences Lead Product Candidate for Alzheimer's Disease Shows Potential for Improved Therapeutic Potency versus Other Amyloid Beta-Directed Antibodies

Humanized PMN310 Shows Significantly Greater Binding to The Toxic Oligomer Fraction of Alzheimer's Disease Brain Extract Compared to...


Jan 23, 2018, 07:30 ET Evofem Biosciences Announces First Patient Enrolled in Phase 2b/3 STI Trial of Amphora® and Expects Phase 3 Contraceptive Clinical Trial Data First Quarter 2019

Evofem Biosciences, Inc., (NASDAQ: EVFM), a clinical-stage specialty biopharmaceutical company focused on the development and commercialization of...


Jan 23, 2018, 07:00 ET Silver Offers Hope of Solving the Antibiotics Crisis - Bacterial Resistance to Nanoparticles can be Averted

Scientists from the Palacký University (UP) in Olomouc have discovered a unique mechanism that enables bacteria to defend themselves against...


Jan 23, 2018, 07:00 ET BioLineRx Reports Data at ASCO-SITC Conference Showing Complete Tumor Regression by AGI-134 in Pre-Clinical Studies

BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX) (TASE: BLRX.TA), a clinical-stage biopharmaceutical company focused on oncology and immunology,...


Jan 23, 2018, 03:18 ET FDA Accepts Investigational New Drug Application and Grants Fast Track Status for SOBI003 for the Treatment of MPS IIIA

Swedish Orphan Biovitrum AB (publ) (Sobi™) announces that the FDA has issued a Study may proceed letter for the first study in humans, thereby...


Jan 22, 2018, 16:30 ET Amgen Reports Aimovig™ (Erenumab) Met All Primary And Secondary Endpoints In Unique Phase 3b Study In Episodic Migraine Patients Who Have Failed Multiple Prior Preventive Treatments

Amgen (NASDAQ:AMGN) today announced positive results from the Phase 3b LIBERTY study assessing the efficacy and safety of Aimovig™ (erenumab) 140...


Jan 22, 2018, 11:01 ET Medeor Therapeutics Awarded $18.8 Million From the California Institute for Regenerative Medicine

Medeor Therapeutics, Inc., a clinical-stage biotechnology company dedicated to the discovery, development and commercialization of personalized...


Jan 22, 2018, 10:46 ET Vyripharm and WardMM announce clinical trial partnership for the integration of traditional standard pharmaceuticals with medical botanicals and the application of big data in precision medicine

Vyripharm Biopharmaceutical (VB) announces a collaboration with WardMM, to establish clinical trial partnership/Joint Venture (JV) for the use of...


Jan 22, 2018, 10:25 ET Pulmatrix Announces Acceptance of a Clinical Trial Application in Europe for Pulmazole - an Inhaled Dry-Powder iSPERSE™ Formulation of Itraconazole

Pulmatrix, Inc. (NASDAQ: PULM), a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary...


Jan 22, 2018, 10:00 ET Agenus Announces Combination Clinical Trials of its Anti-CTLA4 (AGEN1884) & Anti-PD1 (AGEN2034)

Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with a pipeline of immune checkpoint antibodies and cancer vaccines, today announced the...


Jan 22, 2018, 09:00 ET BERG Announces FDA Orphan-Drug Designation of BPM31510 for the Treatment of Pancreatic Cancer

BERG, a Boston-based biopharmaceutical company that merges biology with technology to map the nature of diseases, today announced the U.S. Food and...


Most Viewed